Stephen O'Flanagan

8PUBLICATIONS
58CO-AUTHORS
Haematological tumoursInnate immunityTumour immunologyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 26, 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency.

Jacob A Myers, Rih-Sheng Huang, Shee Kwan Phung

|Apr 15, 2024
Cutting Edge: First Lung Infection Permanently Enlarges Lymph Nodes and Enhances New T Cell Responses.

J Michael Stolley, Milcah C Scott, Stephen D O'Flanagan

|Jun 02, 2023
Chronic antigen in solid tumors drives a distinct program of T cell residence.

Noah V Gavil, Milcah C Scott, Eyob Weyu

|Dec 02, 2022
Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells.

Marco Künzli, Stephen D O'Flanagan, Madeleine LaRue

|May 19, 2022
P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy.

Kelsey M Wanhainen, Changwei Peng, Maggie H Zhou

|Jul 01, 2021
Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.

William E Matchett, Vineet Joag, J Michael Stolley

Pageof 2

Frequent Collaborators

4 joint publications

Sathi Wijeyesinghe

4 joint publications

J Michael Stolley

4 joint publications

Eyob Weyu

3 joint publications

David Masopust